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several alternatives for standard (manual) continuous positive airway pressure
(CPAP) titration are feasible. A practical alternative is titration without polysomno-
graphy during an afternoon nap (Nap-titration). The aim of the present study was to
assess whether Nap-titration is appropriate for effective titration of CPAP.
Following Nap-titration 24 eligible OSAHS patients started conventional CPAP
therapy. The outcome of Nap-titration was verified after 2 weeks with CPAP pressure
adjustments being performed in case of persisting OSAHS symptomatology.
Polysomnography and a questionnaire evaluation were performed at baseline and
8 weeks after Nap-titration.
Following Nap-titration 15 patients did not require pressure changes while in 9
patients’ CPAP pressure was raised due to persisting OSAHS symptomatology. Control
polysomnography after 8 weeks showed successful CPAP titration (Apnea–Hypopnea
Index o5) in 23 out of 24 patients. A pressure raise following polysomnography was
indicated in 1 patient only. In addition, significant improvements were found in
OSAHS symptomatology and quality of life.
This study shows that in 96% of OSAHS patients’ successful CPAP titration is
attained following Nap-titration whether or not supplemented by pressureElsevier Ltd. All rights reserved.
613840; fax: +3150 3611136.
mcg.nl (A. Hoekema).
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A. Hoekema et al.706adjustments. Therefore, Nap-titration with an adequate follow-up appears an
appropriate procedure for the effective titration of CPAP.
& 2005 Elsevier Ltd. All rights reserved.Introduction
The Obstructive Sleep Apnea–Hypopnea Syndrome
(OSAHS) is a highly prevalent sleep-related breath-
ing disorder associated with serious neurocognitive
and cardiovascular sequelae.1 continuous positive
airway pressure (CPAP) is currently recommended
as the treatment of choice for moderate to severe
OSAHS.1 CPAP prevents obstructed breathing events
by pneumatically ‘‘splinting’’ the upper airway
during sleep. Determination of the effective CPAP
pressure (Peff) is usually a trade-off between the
minimisation of pressure-related side-effects and
the prevention of obstructed breathing events. This
procedure, known as CPAP titration, is routinely
conducted by a technician in a sleep laboratory
during attended full-night polysomnography (i.e.
manual titration).2 Manual CPAP titration aims at
identifying the pressure that eliminates apneas,
hypopneas and snoring in all body positions and
sleep stages. Alternative goals in CPAP titration
include the minimisation of oxygen desaturations,
(micro)arousals and inspiratory flow limitations.3
However, currently there are no widely accepted
guidelines on the standardisation of manual CPAP
titration.
Several alternatives for manual titration have
emerged to shorten waiting lists for polysomnogra-
phy and to improve cost-effectiveness of CPAP
titration. Split-night polysomnography for the
diagnosis of OSAHS and titration of CPAP was
introduced to expedite initiation of therapy and
control costs related to polysomnography.4 Daytime
manual CPAP titration during polysomnography has
also been shown a viable alternative for the
efficient and expedient implementation of CPAP in
OSAHS patients.5 Alternative means of titration not
requiring polysomnography include home self-titra-
tion of CPAP based on the detection of snoring or
the patient’s perception of therapeutic comfort
and efficacy.6 Other alternative titration proce-
dures are based on night time respiratory record-
ings or employ prediction equations for Peff based
on polysomnographic and demographic variables.7,8
Moreover, effective CPAP titration not requiring
polysomnographic monitoring has also been per-
formed by means of automatic CPAP devices.8,9
A practical alternative for manual CPAP titration,
especially when polysomnography can only
be conducted ambulatory, is titration withoutpolysomnography during an afternoon nap (Nap-
titration). In our experience Nap-titration deter-
mines an adequate Peff for subsequent CPAP
therapy, although this has not been demonstrated
previously. The aim of the present study was to
assess whether Nap-titration is appropriate for
effective titration of CPAP in OSAHS patients.Methods
Patients
Twenty-nine consecutive patients diagnosed with
OSAHS were considered for inclusion in the present
study. Only ‘‘CPAP-naive’’ patients with an Apnea–
Hypopnea Index (AHI) exceeding 5 were eligible for
inclusion. Patients were excluded in case of
previous OSAHS treatment (1 patient; Oral Appli-
ance therapy), morphological upper airway ab-
normalities requiring surgery (1 patient;
adenotonsillar hypertrophy), endocrine dysfunction
(1 patient; hypothyroidism), predominant central
respiratory events during polysomnography, mod-
erate Periodic Limb Movement Disorder (i.e.
Periodic Limb Movement Index425) or a psycholo-
gical condition precluding informed consent. Of the
remaining 26 patients, one refused participation
and one discontinued treatment shortly following
CPAP titration because of non-compliance. Baseline
characteristics and CPAP-titration data of the 22
male and 2 female patients completing the proto-
col are summarised in Table 1. The study was
approved by the University Medical Center Gronin-
gen ethics board. Written informed consent was
obtained from each participant before initiation of
the protocol.
Protocol
The titration algorithm employed in the present
study is outlined in Fig. 1. At baseline all included
patients were subjected to a basic physical
examination and questionnaire evaluation. Before
CPAP titration during an afternoon nap, patients
received detailed instructions on the titration
procedure and CPAP use by a skilled nursing
consultant. During Nap-titration patients were
allowed to sleep with CPAP in the outpatient clinic
for a 2-h period. Patients were instructed to adopt
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Figure 1 Titration algorithm. Abbreviations: AHI ¼ Apnea–Hypopnea Index; CPAP ¼ Continuous Positive Airway
Pressure; OSAHS ¼ Obstructive Sleep Apnea–Hypopnea Syndrome; Peff ¼ effective CPAP pressure level. Two weeks
following Nap-titration patients return for a follow-up visit. When OSAHS symptomatology has improved adequately
(i.e. a resolution of snoring and improvement in excessive daytime sleepiness), a polysomnographic evaluation is
arranged in 6 weeks. When OSAHS symptomatology persists, CPAP pressure is raised with 1 increment whereupon a
(telephonic) follow-up appointment is arranged after 1 week. Pressure adjustments are continued until OSAHS
symptomatology has improved adequately or until patients complain of pressure intolerance. Thereupon a
polysomnographic evaluation is arranged in 6 weeks. In patients displaying an AHIo5 at polysomnography, CPAP
therapy is considered successful. In case of an AHI45, CPAP pressure is raised with one or two increments whereupon a
second polysomnographic evaluation is performed in 4 weeks. This pressure adjustment sequence is continued until
CPAP is successfully titrated or until patients complain of pressure intolerance.
Table 1 Patient characteristics and CPAP-titration data.
Baseline (n ¼ 24) Follow-up (n ¼ 24) Difference
Mean7SD Mean7SD P value
Age (year) 50.278.1 — —
BMI (kg/m2) 34.476.9 34.276.5 ns
NC (cm) 46.074.1 45.473.7 ns
Peff (cm H2O) 7.071.6 7.671.6 0.004
Titration duration (h) 2.170.2 — —
Abbreviations: BMI ¼ Body Mass Index; NC ¼ neck circumference; ns ¼ non-significant; Peff ¼ effective CPAP pressure level;
SD ¼ standard deviation.
Values corresponding with the last polysomnographic CPAP evaluation.
Alternative CPAP titration 707their own typical sleeping habits during titration.
CPAP pressure was initially set at 5 cm H2O. During
Nap-titration the nursing consultant checked every
15min and intervened in case of difficulties. At
each check CPAP pressure was raised with an 0.5 cm
H2O increment whenever upper airway breathingevents remained noticeable (i.e. audible or visible
signs of apneas, hypopneas or snoring). If after 2 h
of Nap-titration the established Peff resolved all
breathing events, CPAP titration was terminated. If
not, titration was continued as described above for
as long as upper airway breathing events remained
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during (part of) the titration period, the CPAP
pressure established last was used as Peff. Following
Nap-titration CPAP therapy (Breass PV10, Mo¨ln-
lycke, Sweden) was started with the established
Peff.
Two weeks after CPAP initiation patients returned
for their first follow-up visit. Possible difficulties
with the CPAP apparatus were resolved and treat-
ment efficacy was verified. When treatment pro-
gressed without difficulties and OSAHS
symptomatology had improved adequately (i.e. a
resolution of snoring and improvement in excessive
daytime sleepiness (EDS)), a second follow-up visit
and polysomnographic evaluation was arranged in 6
weeks. In case patients reported persistence in
OSAHS symptomatology, CPAP pressure was raised
with one increment. To monitor the outcome of the
pressure adjustment, a (telephonic) follow-up
appointment was arranged after 1 week. The latter
adjustment sequence was repeated until a Peff was
obtained that adequately improved OSAHS sympto-
matology or until further pressure adjustments
were poorly tolerated by patients. Subsequently,
a follow-up visit and polysomnographic evaluation
was arranged in 6 weeks.
Based on the polysomnographic evaluation of the
Peff established during follow-up, it was decided
whether CPAP titration was successful. In patients
displaying an AHIo5, CPAP therapy was considered
successful. Subsequently, the basic physical exam-
ination and questionnaire evaluation performed at
baseline were repeated. In case polysomnography
yielded an AHI45, CPAP titration was continued.
For this purpose CPAP pressure was arbitrarily
raised with one or two increments (depending on
the severity of residual OSAHS with CPAP). Four
weeks following the adjustment in Peff a second
polysomnographic evaluation was performed. This
latter adjustment sequence was continued until
OSAHS was successfully managed (AHIo5) or until
further pressure adjustments were poorly tolerated
by patients. Subsequently, the basic physical
examination and questionnaire evaluation per-
formed at baseline were repeated.Polysomnographic evaluation
Baseline and follow-up polysomnography was con-
ducted ambulatory using the Emblas A10 digital
recorder (Medcare, Reykjavik, Iceland). Each re-
cording started (no later than) 11 AM and termi-
nated 9 AM the next morning. Surface
electroencephalography, submental electromyo-
graphy (EMG), and left and right electrooculogra-phy were used to stage sleep according to
standardised criteria.10 A pulsoximeter (Oximeter
Flex Sensor—8000J-3, Medcare, Reykjavik, Iceland)
was used to record oxyhemoglobin saturation
(SaO2) while electrocardiography was used to
monitor cardiac function. Oronasal airflow was
recorded with a pressure cannula, while respiratory
effort was monitored by thoracic and abdominal
strain gauges. An anterior tibial EMG was recorded
to screen for periodic limb movements. Standar-
dised criteria were used to score breathing
events.11 All recordings were scored by one inter-
preter (JHvdH) who was not informed about the
nature of the recording. Outcomes were limited to
the time in bed of the nocturnal part of the
recording.
Questionnaire evaluation
At baseline and following the last polysomno-
graphic evaluation patients completed the OSAHS-
related symptoms questionnaire, Epworth Sleepi-
ness Scale (ESS), Functional Outcomes of Sleep
Questionnaire (FOSQ), Medical Outcomes Study 36-
Item Short-Form Health Survey (SF-36) and Hospital
Anxiety and Depression Scale (HADS).12–16 CPAP
compliance was evaluated by asking patients how
many nights per week and, in addition to their
mean hours of sleep per night, how many hours per
night CPAP was used. In addition, patients graded
their treatment satisfaction with CPAP on an eleven
point scale (range 0–10; higher scores indicating
better satisfaction).
Analysis
The AHI was used as primary outcome measure with
treatment being considered successful in case of an
AHIo5. Statistical analyses were performed using
the StatsDirect software package version 2.2.3
(Cheshire, UK). Data are summarised by their mean
and standard deviation (SD). Differences between
baseline and follow-up variables were compared
with paired Student’s t-tests. A significance level of
Po0:05 was predefined in all cases (two-sided P
value).Results
Patient characteristics and CPAP-titration data are
summarised in Table 1. CPAP titration lasted 2.1 h
(SD ¼ 0.2) on average and required more than 2 h in 4
patients (range 21423h). All patients reported to
have slept during the predominant part of the
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at 7.0 cm (SD ¼ 1.6) H2O. However, during follow-up
after Nap-titration, pressure changes were re-
quired in 9 patients due to a persistence in OSAHS
symptomatology (4 patients persistence snoring, 5
patients no improvement EDS). Consequently, CPAP
pressure had to be raised with 1 increment in 7
patients, and with 2 and 4 increments, respec-
tively, in the remaining 2 patients. In addition, due
to a persistence of OSAHS at the first polysomno-
graphic evaluation, CPAP pressure was raised with 1
increment in a 10th patient. Consequently, the
mean Peff at the end of the study period was set at
7.6 cm (SD ¼ 1.6) H2O, resulting in a significant
difference between the baseline and follow-up Peff.
Polysomnographic outcomes
Polysomnographic data are summarised in Table 2.
With respect to the primary outcome measure,
successful treatment with CPAP (i.e. AHIo5) was
attained in 23 patients at the first polysomno-
graphic evaluation. In the one patient failing the
criterion for successful CPAP-titration the AHI
decreased from 51 to 7. However, following a 1-
increment pressure raise, the second polysomno-
graphic evaluation also indicated successful OSAHS
management. No significant changes in total sleep
time or sleep efficiency were observed between
baseline and follow-up. However, as a result of
CPAP profound improvements in the AHI and
MinSaO2 were observed. Although no significant
changes in non-rapid eye movement (REM) sleep
stage 1 were observed, the percentage non-REM
sleep stage 2 significantly decreased and the
percentage non-REM sleep stage 3 and 4 and REMTable 2 Polysomnographic outcomes.
Baseline (n ¼ 24)
Mean7SD
TST (min) 382.5785.0
Sleep efficiencyy (%) 81.3717.1
AHI (no/h) 46.6729.4
MinSaO2 (%) 76.3711.9
non-REM 1 (%) 9.2712.9
non-REM 2 (%) 60.2716.6
non-REM 3 (%) 5.377.6
non-REM 4 (%) 7.379.7
REM (%) 18.178.1
Abbreviations: AHI ¼ Apnea–Hypopnea Index ; MinSaO2 ¼ minimu
pid eye movement; SD ¼ standard deviation; TST ¼ total sleep tim
Values corresponding with the last polysomnographic CPAP ev
ySleep efficiency; TST/time in bed 100%.sleep significantly increased as a result of CPAP
initiation.Questionnaire outcomes
Questionnaire data are summarised in Table 3. With
respect to the OSAHS-related symptoms question-
naire and sleepiness according to the ESS, signifi-
cant improvements were seen in response to the
initiation of CPAP therapy. In addition, significant
improvements in excessive sleepiness in all five
subscales of the FOSQ were seen as a result of CPAP
initiation. Conversely, variable outcomes with
respect to the eight SF-36 dimensions were
observed. Whereas role emotional and bodily pain
did not change significantly, CPAP therapy resulted
in significant improvements in the remaining six SF-
36 dimensions. With respect to patient anxiety and
depression, both subscales of the HADS showed
significant improvements as a result of CPAP
initiation.
Except for 3, all studied patients reported using
their CPAP apparatus 7 nights per week (mean 6.9
days, SD ¼ 0.3). During therapeutic nights patients
reported using their CPAP apparatus for a 6.9 h
(SD ¼ 1.5) period. When dividing these values by the
patient reported hours of sleep per night (mean
7.3 h, SD ¼ 1.6), this corresponded with a mean CPAP
use of 96% of each therapeutic night. In addition,
when using CPAP no patient reported using therapy
less than 5 h per night. Twenty-three out of the 24
patients completing the protocol were satisfied
with the effects of CPAP therapy. Patients graded
their treatment satisfaction with a mean of 8.1
(SD ¼ 1.3) points.Follow-up (n ¼ 24) Difference
Mean7SD P value
392.7764.6 ns
84.7710.0 ns
1.171.7 o0.0001
90.874.5 o0.0001
5.673.0 ns
47.6710.8 0.009
9.874.3 0.02
12.776.3 0.02
24.375.5 0.007
m oxyhemoglobin saturation; ns ¼ non-significant; REM ¼ ra-
e.
aluation.
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Table 3 Questionnaire outcomes.
Score-range Direction of
improvement
Baseline
(n ¼ 24)
Follow-up
(n ¼ 24)
Difference
Mean7SD Mean7SD P value
OSAHS-related symptoms 15–60  46.075.3 27.776.2 o0.0001
ESS 0–24  16.574.7 6.374.6 o0.0001
FOSQ:
General productivity 1–4 + 2.770.8 3.570.6 o0.0001
Social outcome 1–4 + 2.771.1 3.570.8 o0.0001
Activity level 1–4 + 2.470.7 3.470.7 o0.0001
Vigilance 1–4 + 2.270.8 3.470.7 o0.0001
Intimate relationships &
sexual activityy
1–4 + 2.571.0 3.271.1 0.006
SF-36:
Physical functioning 0–100 + 62.5727.6 79.4723.1 0.0005
Social functioning 0–100 + 62.7723.9 76.7721.2 0.0004
Role physical 0–100 + 30.2741.7 70.8740.8 0.0001
Role emotional 0–100 + 66.0743.0 80.5736.7 ns
Mental health 0–100 + 64.0718.8 78.3717.3 0.0002
Vitality 0–100 + 33.3719.8 61.7721.8 o0.0001
Bodily pain 0–100 + 77.5727.6 79.8726.8 ns
General health perception 0–100 + 52.3722.6 61.0723.6 0.04
HADS:
Anxiety 0–21  5.973.9 4.173.0 0.006
Depression 0–21  8.673.9 5.574.8 o0.0001
Abbreviations: ESS ¼ Epworth Sleepiness Scale; FOSQ ¼ Functional Outcomes of Sleep Questionnaire; HADS ¼ Hospital Anxiety
and Depression Scale; ns ¼ non-significant; OSAHS ¼ Obstructive Sleep Apnea-Hypopnea Syndrome; SD ¼ standard deviation; SF-
36 ¼ Medical Outcomes Study 36-Item Short-Form Health Survey.
Values corresponding with the last polysomnographic CPAP evaluation.
yn ¼ 21 because 3 patients did not complete this item at baseline and follow-up.
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The present study shows that titration conducted
without polysomnography during an afternoon nap
is an appropriate procedure for the effective
titration of CPAP in OSAHS patients. In addition to
favourable changes in respiratory and sleep related
variables, Nap-titration also resulted in profound
improvements of OSAHS symptomatology. However,
because in 38% of the patients pressure adjust-
ments are indicated following Nap-titration due to
persisting OSAHS symptomatology, an adequate
follow-up is a prerequisite.
With respect to the primary outcome measure,
Nap-titration was successful in yielding an AHIo5 in
nearly all patients following the first polysomno-
graphic evaluation. In addition, successful OSAHS
management was attained in all 24 patients
following a correction of the Peff in 1 patient. The
observed improvements in the AHI are consistent
with results from other studies following manualCPAP titration.17,18 In addition, the improvements
in MinSaO2 are also in keeping with improvements
observed following manual CPAP titration.17,19
Polysomnography following CPAP titration showed
significant changes in non-REM sleep stage 2, 3 and
4, and REM-sleep. These findings suggest pro-
nounced improvements in sleep architecture that
correspond with the effects of CPAP following
manual titration.17–19
In accordance with the polysomnographic out-
comes, most of the questionnaire outcomes sig-
nificantly improved following adequate CPAP
titration. The OSAHS-related symptom question-
naire indicated significant improvements in OSAHS
symptomatology that correspond with other studies
following manual CPAP titration.12,20 In addition,
changes in the ESS and FOSQ values indicated
pronounced improvements in excessive sleepiness
that also correspond with the effects of CPAP
following manual titration.12,20,21 Except for 2 (i.e.
role emotional and bodily pain), Nap-titration
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status in all SF-36 dimensions. Although some
studies show improvements in all SF-36 dimensions
as a result of manual CPAP titration,21 other studies
fail observing such consistent improvements.20
Since the changes in the SF-36 are reported rather
inconsistently, comparison of our findings probably
does not add to the discussion. Finally, following
adequate CPAP titration small but significant
improvements in both patient anxiety and depres-
sion were observed that correspond with the
effects of CPAP following manual titration.22 How-
ever, these latter improvements may also be a
resultant of a placebo effect of CPAP therapy.22 The
observed improvements in questionnaire outcomes
following Nap-titration once again stress the
favourable value of CPAP therapy on patient
symptomatology and quality of life. Both items
being important aspects for obtaining resources for
sleep respiratory medicine.
With economic and practical issues impinging
upon its feasibility, there is an increasing need for
appropriate alternatives to manual CPAP titra-
tion.23 Of the various alternatives propagated,
titration of Peff during an afternoon nap is a
relatively novel procedure. Daytime CPAP titration
has been described previously for the efficient
implementation of CPAP therapy.5 However, in most
of these studies daytime titration was performed
during laboratory polysomnography and required
more than 4 h. Others have suggested CPAP titra-
tion may be performed in a pulmonary department
using Auto-CPAP devices.9 Although sleep labora-
tory intervention may be obviated in this way,
patients are still required to spend the night in
hospital. An alternative means of titration not
requiring polysomnography nor overnight admission
is home self-titration of CPAP based on the
detection of snoring or perception of therapeutic
comfort and efficacy.6 However, self-titration of
CPAP may be regarded as a somewhat arbitrary
means for establishing a Peff. Split-night polysom-
nography was introduced to expedite therapeutic
intervention and control (polysomnographic) costs.
Nevertheless, split-night polysomnography must be
performed under sleep-laboratory conditions and
may still require a change in the prescribed
pressure.4 In addition, alternative means of CPAP
titration that employ prediction equations for Peff
based on polysomnographic and anthropometric
variables, may still require adjustments in CPAP
pressure in 28% of patients because of persisting
OSAHS symptomatology.8 Nap-titration with an
adequate follow-up regime allowed for adequate
CPAP titration in an outpatient setting. Therefore,
Nap-titration does not require access to asleep-laboratory nor time-consuming titration
procedures. Because polysomnography indicated
successful CPAP titration in 23 out of 24 patients
at follow-up, a polysomnographic CPAP evaluation
following Nap-titration does not appear obligatory.
Thereby, polysomnographic control recordings may
be reserved for specific cases (e.g. persisting
OSAHS symptomatology despite apparent adequate
titration). Moreover, provided adequate knowledge
of pulmonary medicine and respiratory support is
present, Nap-titration may be performed by nursing
consultants.
The Peff attained at the end of the study period
(i.e. 7.6 cm H2O, SD ¼ 1.6) is comparable to pres-
sures obtained with manual CPAP titration in
patients with similar OSAHS gravity.5,17 Despite
the adequate Peff, pressure changes were required
in a considerable proportion of patients following
Nap-titration. The latter was indicated due to the
persistence in OSAHS symptomatology in 9 patients
following Nap-titration and OSAHS persistence
following the polysomnographic evaluation in a
10th patient. The significant difference in Peff
between baseline and follow-up may be explained
by several factors. Firstly, although patients re-
ported to have slept during predominant part of the
titration period, this was not objectified. There-
fore, it cannot be excluded that the 2 h nap did not
provide a sufficient time window to accurately
titrate a Peff that abolished all obstructed breathing
events. Secondly, it could be argued that the
relatively short sleeping period during Nap-titration
does not allow for an adequate amount of REM
sleep. It is commonly accepted that, as a result of
greater upper airway collapsibility, REM sleep
requires higher CPAP levels than non-REM sleep.
As a resultant, a lower pressure may be titrated
than truly is required. Consequently, obstructed
breathing events may be eliminated during Nap-
titration whereas not during a convential night in
the patient’s home situation. However, recent
studies with Auto-CPAP devices suggest that the
highest CPAP levels may actually be required during
stage 1 non-REM sleep.24 Thirdly, the ‘‘end-point’’
of Nap-titration may also explain the discrepancy in
Peff. Although Nap-titration is aimed at eliminating
snoring, flow limitations are probably a more
sensitive marker of upper airway obstruction.25
Therefore, a persistence in OSAHS symptomatology
following Nap-titration may be explained by the
fact that in some patients obstructed breathing
events were not adequately eliminated. However,
the need for elimination of airflow limitations in
CPAP titration is still a controversial topic.26
Potential improvements with the elimination of
flow limitations should always be balanced by the
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leakage due to higher CPAP pressures. In conclu-
sion, it appears that the origin for the observed
discrepancy in Peff between baseline and follow-up
is multifactorial. Despite the significantly lower Peff
following Nap-titration, adequate CPAP titration
was accomplished in 23 out of 24 patients by
arbitrarily raising the pressure in the presence of
persisting OSAHS symptomatology. The latter tech-
nique has also been employed by others and proven
to be practical and efficacious.6,8 Therefore, when
the outcome of Nap-titration is verified by an
adequate follow-up with pressure adjustments
being performed when indicated, it may be
considered an appropriate procedure.
Some methodological limitations may compro-
mise the implications of the present study.
Although standard guidelines have not been estab-
lished and its reproducibility is not well known,27
manual CPAP titration is considered the ‘‘reference
standard’’ for CPAP titration. Because in our
hospital polysomnography is conducted on an
ambulatory basis, a comparative study on the
precise relationship between Nap-titration and
manual CPAP titration was not feasible. However,
by defining successful titration as an AHIo5, we
conformed to a generally accepted criterion for
optimal CPAP efficacy.28 Therefore, despite the lack
of manual titration as ‘‘reference standard’’, the
present titration technique was contrasted to a
valid standard. Secondly, pressure adjustments at
the 2week follow-up after Nap-titration were only
guided by subjective criteria (i.e. OSAHS sympto-
matology) and not polysomnographic data. There-
fore, there is a potential risk with the present
titration protocol of titrating unnecessary high
pressures than truly are required. With higher CPAP
pressures the risk of pressure intolerance and nasal
problems is more conceivable. However, problems
that may result from higher CPAP pressures were
not encountered in any of the subjects studied. In
addition, as previously mentioned, pressures ob-
tained at follow-up were comparable to pressures
obtained in other studies with manual CPAP titra-
tion.5,17 We therefore believe that the Peff derived
from Nap-titration with an adequate follow-up is
not higher than truly is required. Finally, CPAP
compliance was not objectified in the present
study. Instead, patients were asked to report their
compliance. It has been reported that self-reports
are unable to distinguish between compliant and
non-compliant patients.29 However, other studies
reported that, although patients may over-report
their CPAP use by a small amount, there is a good
correlation between self-reported and objectively
measured CPAP compliance.30 In the present studythe patient reported compliance was adequate
with an average CPAP use of 6.9 days per week and
6.9 h per night, respectively. In addition, patients
reported using CPAP for a minimum of 5 h per night,
which may be considered satisfactory.31 Moreover,
contrary to the specific titration technique, evi-
dence from systematic literature review suggests
that an adequate education and support pro-
gramme is more important to achieve favourable
CPAP compliance when initiating therapy.31 By
employing skilled nursing consultants and an
intensive follow-up regime the later provision was
believed to be adequately met in the present study.
It is concluded that a CPAP pressure derived from
Nap-titration with an adequate follow-up regime is
efficacious in the management of OSAHS. This
relatively novel procedure yields similar improve-
ments in most objective and subjective outcomes
when compared with other studies following
manual CPAP titration. Despite the adequate
titration of CPAP in all patients completing the
study, pressure changes were required in a con-
siderable proportion of patients following Nap-
titration. The latter phenomenon appears to be
related to multiple causes and stresses the neces-
sity for an adequate follow-up after Nap-titration.Acknowledgements
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